Up-regulation of flk-1/vascular endothelial growth factor receptor 2 by its ligand in a cerebral slice culture system

Cancer Research

Volumn 57, Issue 17, 1997, Pages 3852-3859

  Kremer, Christine ^a   Breier, Georg ^b   Risau, Werner ^b   Plate, Karl H ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

^b MAX PLANCK INSTITUTE FOR HEART AND LUNG RESEARCH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN TYROSINE KINASE; VASCULOTROPIN;

ANIMAL TISSUE; ARTICLE; BRAIN DEVELOPMENT; BRAIN SLICE; EMBRYO DEVELOPMENT; FEMALE; GENE EXPRESSION; HYPOXIA; IMMUNOHISTOCHEMISTRY; MALE; MOUSE; NEUROECTODERM; NONHUMAN; PRIORITY JOURNAL; RECEPTOR UPREGULATION;

ANIMALS; ANTIGENS, CD31; BRAIN; CELL HYPOXIA; CELLS, CULTURED; ENDOTHELIAL GROWTH FACTORS; FEMALE; HUMANS; LIGANDS; LYMPHOKINES; MALE; MICE; MICE, INBRED BALB C; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTORS, GROWTH FACTOR; RECEPTORS, VASCULAR ENDOTHELIAL GROWTH FACTOR; RNA, MESSENGER; UP-REGULATION; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0030800782     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (58)

1. Ferrara, N. Vascular endothelial growth factor. Trends Cardiovasc. Sci., 3: 244-250, 1993.
2. Klagsbrun, M., and Soker, S. VEGF/VPF: the angiogenesis factor found? Curr. Biol., 3: 699-702, 1993.
3. Plate, K. H., Breier, G., and Risau, W. Molecular mechanisms of developmental and tumor angiogenesis. Brain Pathol., 4: 207-218, 1994.
4. Hanahan, D., and Folkman, J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell, 86: 353-364, 1996.
5. Shalaby, F., Rossant, J., Yamaguchi, T. P., Gertsenstein, M., Wu, X. F., Breitman, M. L., and Schuh, A. C. Failure of blood-island formation and vasculogenesis in flk-1 deficient mice. Nature (Lond.), 376: 62-66, 1995.
6. Carmeliet, P., Ferreira, V., Breier, G., Pollefeyt, S., Kieckens, L., Gertsenstein, M., Fahrig, M., Vandenhoeck, A., Harpal, K., Eberhard, C., Desclerc, C., Pawling, M., Moons, L., Collen, D., Risau, W., and Nagy, A. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature (Lond.), 380: 435-439, 1996.
7. Ferrara, N., Carver-Moore, K., Chen, H., Dowd, M., Lu, L., O'Shea, K. S., Powell-Braxton, L., Hillan, K., and Moore, M. W. Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature (Lond.), 380: 439-442, 1996.
8. Kovács, Z., Ikezaki, K., Samoto, K., Inamura, T., and Fukui, M. VEGF and flt. Expression time kinetics in rat brain infarct. Stroke, 27: 1865-1873, 1996.
9. Adamis, A. P., Shima, D, T., Yeo, K-T., Brown, L. F., Berse, B., D'Amore, P. A., and Folkman, J. Synthesis and secretion of vascular permeability factor/vascular endothelial growth factor by human retinal pigment epithelial cells. Biochem. Biophys. Res. Commun., 193: 631-638, 1993.
10. Pertovaara, L., Kaipanen, A., Mustonen, T., Orpana, A., Ferrara, N., Saksela, O., and Alitalo, K. Vascular endothelial growth factor is induced in response to transforming growth factor-β in fibroblastic and epithelial cells. J. Biol. Chem., 269: 6271-6274, 1994.
11. Berse, B., Brown, L. F., Van De Water, L., Dvorak, H. F., and Senger, D. R. Vascular permeability factor (vascular endothelial growth factor) is expressed differentially in normal tissue, macrophages, and tumors. Mol. Biol. Cell, 3: 211-220, 1992.
12. Shweiki, D., Itin, A., Soffer, D., and Keshet, E. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature (Lond.), 359: 843-845, 1992.
13. Senger, D., Peruzzi, C. A., Feder, J., and Dvorak, H. F. A highly conserved vascular permeability factor secreted by a variety of human and rodent cell lines. Cancer Res., 46: 5629-32, 1986.
14. Conn, G., Sodermann, D. D., Schaeffer, M-T., Wile, M., Hatcher, V. B., and Thomas, K. A. Purification of a glycoprotein vascular endothelial cell mitogen from a rat glioma-derived cell line. Proc. Natl. Acad. Sci. USA 87: 1323-1327, 1990.
15. Brown, L. F., Berse, B., Jackman, R. W., Tognazzi, K., Manseau, E. J., Dvorak, H., and Senger, D. R. Increased expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in kidney and bladder carcinomas. Am. J. Pathol., 143: 1255-1262, 1993.
16. Plate, K. H., Breier, G., Weich, H. A., Mennel, H. D., and Risau, W. Vascular endothelial growth factor and glioma angiogenesis: coordinate induction of VEGF-receptors, distribution of VEGF protein and possible in vivo regulatory mechanisms. Int. J. Cancer, 59: 520-529, 1994.
17. Takeshita, S., Zheng, L. P., Brogi, E., Kearney, M., Pu, L-Q., Bunting, S., Ferrara, N., Symes, J. F., and Isner, J. M. Therapeutic angiogenesis. J. Clin. Invest., 93: 662-670, 1994.
18. Kim, J. B., Li, B., Winer, J., Armanini, M., Gillett, N., Philipps, H. S., and Ferrara, N. Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo. Nature (Lond.), 362: 841-844, 1993.
19. Saleh, M., Stacker, S. A., and Wilks, A. F. Inhibition of growth of C6 glioma cells in vivo by expression of antisense vascular endothelial growth factor sequence. Cancer Res., 56: 393-401, 1996.
20. Cheng, S. Y., Huang, H. J. S., Nagane, M., Ji, X. D., Wang, D. G., Shih, C. C. Y., Arap, W., Huang, C. M., and Cavenee, W. K. Suppression of glioblastoma angiogenicity and tumourigenicity by inhibition of endogenous expression of vascular endothelial growth factor. Proc. Natl. Acad. Sci. USA, 93: 8502-8507, 1996.
21. Millauer, B., Shawer, L., Plate, K. H., Risau, W., and Ullrich, A. Glioblastoma growth inhibited in vivo by a dominant-negative Flk-1 mutant. Nature (Lond.), 367: 576-579, 1994.
22. Millauer, B., Longhi, M. P., Plate, K. H., Shawver, L. K., Risau, W., Ullrich, A., and Strawn, L. M. Dominant-negative inhibition of Flk-1 suppresses the growth of many tumor types in vivo. Cancer Res., 56: 1615-1620, 1996.
23. Ikeda, E., Achen, M. G., Breier, G., and Risau, W. Hypoxia-induced transcriptional activation and increased mRNA stability of vascular endothelial growth factor (VEGF) in C6 glioma cells. J. Biol. Chem., 270: 19761-19766, 1995.
24. Forsythe, J. A., Jiang, B-H., Iyer, N. V., Agani, F., Leung, S. W., Koos, R. D., and Semenza, G. L. Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Mol. Cell. Biol., 16: 4604-4613, 1996.
25. Levy, A. P., Levy, N. S., and Goldberg, M. A. Post-transcriptional regulation of vascular endothelial growth factor by hypoxia. J. Biol. Chem., 271: 2746-2753, 1996.
26. Millauer, B., Wizigmann-Voos, S., Schnürch, H., Martinez, R., Moller, N., Risau, W., and Ullrich, A. High affinity VEGF binding and developmental expression suggests Flk-1 as a major regulator of angiogenesis and vasculogenesis. Cell, 72: 835-846, 1993.
27. Breier, G., Clauss, M., and Risau, W. Coordinate expression of vascular endothelial growth factor receptor-1 (flt-1) and its ligand suggests a paracrine regulation of murine vascular development. Dev. Dyn., 204: 228-239, 1995.
28. Waltenberger, J., Claesson-Welsh, L., Siegbahn, A., Shibuya, M., and Heldin, C. H. Different signal transduction properties of KDR and Flt-1, two receptors for vascular endothelial growth factor. J. Biol. Chem., 269: 26988-26995, 1994.
29. Plate, K. H., Breier, G., Millauer, B., Ullrich, A., and Risau, W. Upregulation of vascular endothelial growth factor and its cognate receptors in a rat glioma model of tumor angiogenesis. Cancer Res., 53: 5822-5827, 1993.
30. Clauss, M., Breier, G., Knies, U., Rockl, W., Waltenberger, J., and Risau, W. The vascular endothelial growth factor receptor Flt-1 mediates biological activities. Implications for a functional role of placenta growth factor in monocyte activation and chemotaxis. J. Biol. Chem., 271: 17629-17634, 1996.
31. Brogi, E., Schatteman, G., Kim, E. A., Varticovski, L., Keyt, B., and Isner, J. M. Hypoxia-induced paracrine regulation of vascular endothelial growth factor receptor expression. J. Clin. Invest., 97: 469-476, 1996.
32. Terman, B. C., Dougher-Vermazen, M., Carrion, M. E., Dimitrov, D., Armellino, D. C., Gospodarowicz, D., and Bohlen, P. Identification of the KDR tyrosine kinase as a receptor for vascular endothelial growth factor. Biochem Biophys. Res. Commun., 187: 1579-1586, 1992.
33. Heldin, C-H. Structural and functional studies on platelet-derived growth factor. EMBO J., 11: 4251-4259, 1992.
34. Kourembanas, S., Hannan, R. L., and Faller, DV. Oxygen tension regulates the expression of the platelet-derived growth factor-B chain gene in human endothelial cells. J. Clin. Invest., 86: 670-674, 1990.
35. Risau, W., Drexler, H., Mironov, V., Smits, A., Siegbahn, A., Funa, K., and Heldin, C-H. Platelet-derived growth factor is angiogenic in vivo. Growth Factors, 7: 261-266, 1992.
36. Beitz, J. G., Kim, I., Calabresi, P., and Frackelton, A. R., Jr. Human microvascular endothelial cells express receptors for platelet-derived growth factor. Proc. Natl. Acad. Sci. USA, 88: 2021-2025, 1991.
37. Plate, K. H., Breier, G., Farrell, C., and Risau, W. Platelet-derived growth factor receptor-β is induced during tumor development and upregulated during tumor progression in endothelial cells in human gliomas, Lab. Invest., 67: 529-534, 1992.
38. Park, J. E., Chen, H. H., Winer, J., Houck, K. A., and Ferrara, N. Placenta growth factor. J. Biol. Chem., 269: 25646-25654, 1994.
39. Gleadle, J. M., Ebert, B. L., Firth, J. D., and Ratcliff, P. J. Regulation of angiogenic growth factor expression by hypoxia, transition metals, and chelating agents. Am. J. Cell. Physiol., 17: C1362-C1368, 1995.
40. Marti, H. H., Wenger, R. H., Rivas, L. A., Straumann, U., Digicaylioglu, M., Henn, V., Yonekawa, Y., Bauer, C., and Gassmann, M. Erythropoietin expression in human, monkey and murine brain. Eur. J. Neurosci., 8: 666-676, 1996.
41. Anagnostou, A., Liu, Z., Steiner, M., Chin, K., Lee, E. S., Kessimian, N., and Noguchi, C. T. Erythropoietin receptor mRNA expression in human endothelial cells. Proc. Natl. Acad. Sci. USA, 91: 3974-3978, 1994.
42. Breier, G., Albrecht, U., Sterrer, S., and Risau, W. Expression of vascular endothelial growth factor during embryonic angiogenesis and endothelial cell proliferation. Development (Camb.), 114: 521-532, 1992.
43. Plate, K. H., Breier, G., Weich, H. A., and Risau, W. Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo. Nature (Lond.), 359: 845-848, 1992.
44. Yamaguchi, T. P., Dumont, D. J., Conlon, R. A., Breitman, M. L., and Rossant, J. flk-1, an flt-1 related receptor tyrosine kinase is an early marker for endothelial cell precursors. Development (Camb.), 118: 489-498, 1993.
45. Robertson, P. L., Du Bois, M., Bowman, P. D., and Goldslein, G. W. Angiogenesis in the developing rat brain: an in vivo and in vitro study. Dev. Brain Res., 23: 219-223, 1985.
46. Folkman, J. Angiogenesis in cancer, vascular, rheumathoid and other disease. Nat. Med., 1: 27-31, 1995.
47. Kanno, H., Kondo, K., Ito, S., Yamamoto, I., Fujii, S., Torigoe, S., Sakai, N., Hosaka, M., Shuin, T., and Yao, M. Somatic mutations of the von Hippel-Lindau tumor suppressor gene in sporadic central nervous system hemangio-blastomas. Cancer Res., 54: 4845-4847, 1994.
48. Wizigmann-Voos, S., Breier, G., Risau, W., and Plate, K. H. Up-regulation of vascular endothelial growth factor and its receptors in von Hippel-Lindau-disease associated and in sporadic hemangioblastomas. Cancer Res., 55: 1358-1364, 1995.
49. Wizigmann-Voos, S., and Plate, K, H. Pathology, genetics and cell biology of hemangioblastomas. Histol. Histopathol., 11: 1049-1061, 1996.
50. Siemeister, G., Weindel, K., Mohrs, K., Barleon, B., Martiny-Baron, G., and Marmé, D. Reversion of deregulated expression of vascular endothelial growth factor in human renal cell carcinoma cells by von Hippel-Lindau tumor suppressor protein. Cancer Res., 56: 2299-2301, 1996.
51. Iliopoulos, O., Levy, A. P., Jiang, C., Kaelin, W. G., Jr., and Goldberg, M. A. Negative regulation of hypoxia-inducible genes by the von Hippel-Lindau protein. Proc. Natl. Acad. Sci. USA, 93: 10595-10599, 1996.
52. Flamme, I., von Reutern, M., Drexler, H. C. A., Syed-Ali, S., and Risau, W. Overexpression of vascular endothelial growth factor in the avian embryo induces hypervascularization and increased vascular permeability without alterations of embryonic pattern formation. Dev. Biol., 171: 399-414, 1995.
53. Wilting, J., Birkenhäger, R., Eichmann, A., Kurz, H., Martiny-Baron, G., Marmé, D., McCarthy, J. E. G., Christ, B., and Weich, H. A. VEGF121 induces proliferation of vascular endothelial cells and expression of flk-1 without affecting lymphatic vessels of the chorioallantoic membrane. Dev. Biol., 176: 76-85, 1996.
54. Waltenberger, J., Mayr, U., Pentz, S., and Hombach, V. Functional upregulation of the vascular endothelial growth factor receptor KDR by hypoxia. Circulation, 94: 1647-1654, 1996.
55. Tilly, J. L., LaPolt, P. S., and Hsueh, A. J. Hormonal regulation of follicle-stimulating hormone receptor messenger ribonucleic acid levels in cultured rat granulosa cells. Endocrinology, 130: 1296-1302, 1992.
56. Zhou, Q. Y., Li, C., and Civelli, O. Characterization of gene organization and promoter region of the rat dopamine D1 receptor gene. J. Neurochem., 59: 1875-1883, 1992.
57. Testa, U., Pelosi, E., and Peschl, C. The transferrin receptor. Crit. Rev. Oncog., 4: 241-276, 1993.
58. Dalkin, A. C. Haisenleder, D. J., Yasin, M., Gilrain, J. T., and Marshall, J. C. Pituitary activin receptor subtypes and follistatin gene expression in female rats: differential regulation by activin and follistatin. Endocrinology, 137: 548-554, 1996.